R3 Vascular
$87.0M
Funding date
Valuation / Funding
No funding history available
Funding data has not been imported for this company yet
Current Valuation Metrics
R3 Vascular is currently valued at $145.0M as of May 9, 2024. The company has raised a total of $105.6M in funding.
Capital Efficiency
With a capital efficiency ratio of 1.37x, R3 Vascular has achieved a valuation that is 1.37 times the total capital raised. This metric indicates room for improvement in capital deployment.
Investment Perspective
R3 Vascular's valuation reflects investor confidence in the company's market position, growth potential, and ability to execute on its business model. Private market valuations are determined by primary funding rounds and secondary market transactions, which take into account financial performance, market conditions, and growth prospects.
What is R3 Vascular Worth in 2025?
As of 2025, R3 Vascular is valued at $145.0M, based on the company's Later Stage VC funding round in May 9, 2024. This valuation positions R3 Vascular as one of the leading private companies in the sector.
R3 Vascular Valuation History
R3 Vascular's funding history demonstrates steady growth and investor confidence.
How R3 Vascular Valuation is Determined
Private company valuations like R3 Vascular's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including:
- Revenue growth and financial performance
- Market opportunity and total addressable market (TAM)
- Competitive positioning and market share
- Management team strength and execution capability
- Technology and intellectual property
- Industry trends and investor sentiment
R3 Vascular Valuation FAQs
Is R3 Vascular profitable?
R3 Vascular has not publicly disclosed its profitability status. Many high-growth private companies prioritize market expansion and user growth over profitability in their early stages.
How does R3 Vascular's valuation compare to competitors?
R3 Vascular is valued at $145.0M, positioning it as a major player in the space. Secondary market pricing and private market transactions provide ongoing validation of this valuation.
When will R3 Vascular IPO?
R3 Vascular has not announced plans for an initial public offering. Until an IPO, investors can access R3 Vascular shares through secondary market platforms.